Skip to main content
Fig. 1 | Journal of Hematology & Oncology

Fig. 1

From: Combating head and neck cancer metastases by targeting Src using multifunctional nanoparticle-based saracatinib

Fig. 1

Saracatinib effectively inhibits Src phospho-activation and migration in HNSCC cells. a The effects of shRNAs against Src on the expression of Src protein. b The effects of Src knockdown on cell migration within 24 h. c The effects of saracatinib and dasatinib on the phosphorylation levels of Src. d The effects of saracatinib and dasatinib on cell migration within 24 h. b, d The representative images and quantitative data were shown in the left and right panels, respectively. *p < 0.05; **p < 0.01

Back to article page

Journal of Hematology & Oncology

ISSN: 1756-8722

Contact us